A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients

NCT00088140 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: IDN-6556
DRUG: Placebo

Sponsor

Conatus Pharmaceuticals Inc.

Collaborators

[object Object]